Providing straightforward information pertaining to drugs, drug use & drug policy. The Grey Pages promotes drug-related literacy and advocates a system of viable and tolerant drug policies. This is my personal collection of commentaries, essays, tid-bits, and other such writings on everything ranging from drug use, drug policy and drug-myths, to drug-science, addiction, human behavior, and the workings of the human brain. I started this blog with a particular focus on opioids, and over the past year have found my interest gravitate toward the intriguing, ever-changing world of designer intoxicants (i.e. "research chemicals" or "designer drugs").

Friday, October 15, 2010

3-MeO-PCP Vault

(Also known as 3-methoxy-phencyclidine)

3-MeO-PCP is a psychoactive drug of the dissociative family, which in recent years has been distributed as a research chemical (i.e. designer drug). It possesses psychedelic, euphorigenic, and sedative properties. 

This compound is an arylcyclohexylamine derivative, and an analogue of PCP (phencyclidine). 3-MeO-PCP is about equal in potency to PCP, or about 10x more potent than its 4-MeO analogue.

3-MeO-PCP is believed to act as an NMDA receptor antagonist, and as a dopamine reuptake inhibitor.3-MeO-PCP

No comments:

Post a Comment